Alerts will be sent to your verified email
Verify Email
FREDUN
|
Fredun Pharma
|
Syncom Formulations
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.84 % | 9.79 % | 15.1 % |
|
5yr average Equity Multiplier
|
2.85 | 1.41 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
1.08 | 0.81 | 0.82 |
|
5yr Avg Net Profit Margin
|
3.9 % | 8.78 % | 14.59 % |
|
Price to Book
|
8.28 | 3.38 | 1.87 |
|
P/E
|
39.83 | 18.54 | 15.23 |
|
5yr Avg Cash Conversion Cycle
|
175.29 Days | 61.57 Days | -6.41 Days |
|
Inventory Days
|
146.68 Days | 27.32 Days | 43.91 Days |
|
Days Receivable
|
142.46 Days | 82.75 Days | 91.75 Days |
|
Days Payable
|
112.95 Days | 79.41 Days | 128.38 Days |
|
5yr Average Interest Coverage Ratio
|
2.62 | 31.44 | 63.13 |
|
5yr Avg ROCE
|
22.71 % | 13.63 % | 19.81 % |
|
5yr Avg Operating Profit Margin
|
9.7 % | 9.97 % | 18.35 % |
|
5 yr average Debt to Equity
|
0.93 | 0.19 | 0.0 |
|
5yr CAGR Net Profit
|
25.5 % | 36.24 % | 5.76 % |
|
5yr Average Return on Assets
|
4.18 % | 7.11 % | 11.92 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.17 % | 50.57 % | 49.78 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-5.98 % | 0.0 | 2.78 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Fredun Pharma
|
Syncom Formulations
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|